BAD/BCL-xL heterodimerization leads to bypass of G0/G1 arrest

Anuja Chattopadhyay, Chi Wu Chiang, Elizabeth Yang

研究成果: Article同行評審

54 引文 斯高帕斯(Scopus)

摘要

The pro-apoptotic molecule BAD binds BCL-xL or BCL2 and inactivates their survival function. In addition to their anti-apoptotic function, BCL2 and BCL-xL also delay cell cycle entry from quiescence. We found that the BH3-only molecule BAD also exerted a cell cycle effect. BAD expression resulted in failure to cell cycle block in growth arrest conditions. In low serum and in confluence, fibroblasts constitutively or inducibly expressing BAD persisted in S phase, continued to incorporate BrdU, and exhibited sustained cyclin E/cdk2 activity. Mutation analysis indicated that the cell cycle effect of BAD was not dependent on its phosphorylation status or subcellular localization, but strictly co-segregated with BCL-xL binding, bclx-/- MEFs expressing BAD and bad-/- MEFs both arrested in G0/G1 in low serum similar to wild-type controls, suggesting that the ability to overcome the G0/G1 checkpoint resulted from the presence of BAD/BCL-xL heterodimers, rather than the absence of BCL-xL or BAD. These data provide evidence that in addition to regulating apoptosis, the BAD/BCL-xL heterodimer has a novel cell cycle function.

原文English
頁(從 - 到)4507-4518
頁數12
期刊Oncogene
20
發行號33
DOIs
出版狀態Published - 2001 7月 27

All Science Journal Classification (ASJC) codes

  • 分子生物學
  • 遺傳學
  • 癌症研究

指紋

深入研究「BAD/BCL-xL heterodimerization leads to bypass of G0/G1 arrest」主題。共同形成了獨特的指紋。

引用此